Zaharan, N. L.
10  Ergebnisse:
Personensuche X
?
2

Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinet..:

Mac Guad, R. ; Zaharan, N.L. ; Chik, Z....
Transplantation Proceedings.  48 (2016)  1 - p. 81-87 , 2016
 
?
3

Disparities in health-related quality of life among healthy..:

Loh, D. A. ; Moy, F. M. ; Zaharan, N. L..
Child: Care, Health and Development.  41 (2015)  6 - p. 1216-1226 , 2015
 
?
4

Prescribing of antidiabetic therapies in Ireland: 10-year t..:

Zaharan, N. L. ; Williams, D. ; Bennett, K.
Irish Journal of Medical Science.  183 (2013)  2 - p. 311-318 , 2013
 
?
5

Irish Medicines Board safety warnings: do they affect presc..:

Musleh, S. ; Kraus, S. ; Bennett, K..
Pharmacoepidemiology and Drug Safety.  20 (2011)  9 - p. 979-986 , 2011
 
?
6

Hypertension in Ireland: public awareness and doctors choic..:

Zaharan, N. L. ; Mahmud, A. ; Bennett, K..
Irish Journal of Medical Science.  178 (2009)  4 - p. 413-417 , 2009
 
?
7

Safety and efficacy of two tacrolimus formulations (Prograf..:

Mac Guad, R ; Zaharan, N. L ; Wan Md Adnan, W. A.H..
Mac Guad , R , Zaharan , N L , Wan Md Adnan , W A H , Bin Chik , Z & Gan , S H 2019 , ' Safety and efficacy of two tacrolimus formulations (Prograf® and advagraf®) in Malaysian renal transplant patients : A comparative study ' , Journal of Health and Translational Medicine , vol. 22 , no. 1 , pp. 20-26 . https://doi.org/10.22452/jummec.vol22no1.4.  , 2019
 
?
10

Non-Synonymous Single-Nucleotide Polymorphisms and Physical..:

Nur Lisa Zaharan ; Nor Hanisah Muhamad ; Muhammad Yazid Jalaludin...
http://journal.frontiersin.org/article/10.3389/fendo.2018.00209/full.  , 2018
 
1-10